Minimal Residual Disease Dynamic Monitoring in First-Line Serplulimab Plus Chemotherapy in Treatment of Extensive Small Cell Lung Cancer: An Observational Study
Clinical trial NCT05873790 · UNKNOWN
Trial details
- NCT number
- NCT05873790
- Sponsor
- The First Hospital of Jilin University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-06-01
- Primary completion
- 2024-06-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.